Literature DB >> 16167945

XY females: revisiting the diagnosis.

Catherine L Minto1, Naomi S Crouch, Gerard S Conway, Sarah M Creighton.   

Abstract

OBJECTIVES: To investigate the accuracy of assigned diagnosis in XY female intersex conditions.
DESIGN: Cross sectional hospital case notes review.
SETTING: Tertiary hospital multidisciplinary intersex clinic. SAMPLE: Forty-six adult intersex women with a complete or mosaic XY karyotype.
METHODS: All clinical features and investigation results were reviewed and a diagnosis was assigned. This was compared to the original diagnosis assigned. MAIN OUTCOME MEASURES: Data collected included presentation, all investigations, subsequent clinical course and all treatments (medical and surgical). These data were employed to assign an up-to-date intersex diagnosis, which was compared with the recorded diagnosis in the hospital case notes. Diagnoses were then rated according to level of accuracy.
RESULTS: The 47.8% patients had an accurate diagnosis, 32.6% of diagnoses were inaccurate and currently under review, 13% had a wrong diagnosis and 6.5% remain with an unknown aetiology for their XY intersex condition.
CONCLUSIONS: Diagnostic accuracy is assumed to be high when evaluating published work on these conditions; however, this study shows 52.1% of patients have unknown, inaccurate or wrong diagnoses. Assigning the wrong diagnosis may be harmful, for example, if it leads to irreversible virilising changes or development of a gonadal malignancy, and for all cases excludes accurate condition management and genetic counselling for both the patient and their immediate family.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16167945     DOI: 10.1111/j.1471-0528.2005.00664.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  6 in total

Review 1.  Germ cell neoplasia in situ complicating 17β-hydroxysteroid dehydrogenase type 3 deficiency.

Authors:  Lisal J Folsom; Mariam Hjaige; Jiayan Liu; Erica A Eugster; Richard J Auchus
Journal:  Mol Cell Endocrinol       Date:  2018-11-30       Impact factor: 4.102

Review 2.  Transition of care for adolescents with disorders of sex development.

Authors:  Naomi S Crouch; Sarah M Creighton
Journal:  Nat Rev Endocrinol       Date:  2014-05-20       Impact factor: 43.330

Review 3.  Holistic management of DSD.

Authors:  Caroline E Brain; Sarah M Creighton; Imran Mushtaq; Polly A Carmichael; Angela Barnicoat; John W Honour; Victor Larcher; John C Achermann
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-04       Impact factor: 4.690

4.  Hormone replacement treatment choices in complete androgen insensitivity syndrome: an audit of an adult clinic.

Authors:  Jennifer K Y Ko; Thomas F J King; Louise Williams; Sarah M Creighton; Gerard S Conway
Journal:  Endocr Connect       Date:  2017-06-14       Impact factor: 3.335

5.  Complete Androgen Insensitivity Syndrome: From the Relevance of an Accurate Genetic Diagnosis to the Challenge of Clinical Management. A Case Report.

Authors:  Federica Barbagallo; Rossella Cannarella; Matteo Bertelli; Andrea Crafa; Sandro La Vignera; Rosita A Condorelli; Aldo E Calogero
Journal:  Medicina (Kaunas)       Date:  2021-10-21       Impact factor: 2.430

6.  Next-Generation Sequencing Reveals Novel Genetic Variants (SRY, DMRT1, NR5A1, DHH, DHX37) in Adults With 46,XY DSD.

Authors:  Federica Buonocore; Oliver Clifford-Mobley; Tom F J King; Niccolò Striglioni; Elim Man; Jenifer P Suntharalingham; Ignacio Del Valle; Lin Lin; Carlos F Lagos; Gill Rumsby; Gerard S Conway; John C Achermann
Journal:  J Endocr Soc       Date:  2019-10-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.